Andaç Celasun Alsina, Federico Sacchetti, Hüseyin Kaya, Banu Yaman, İpek Tamseli, Dündar Sabah

Impact of the unplanned excision on the oncological outcomes of patients with soft tissue sarcomas: a single-center retrospective review of 490 patients

Objective: This study aimed to (1) compare the oncological results of patients who underwent re-excision after unplanned excision with those who underwent planned excision and (2) analyze the impact of local recurrences on oncological outcomes. Methods: Patients with soft tissue sarcoma who had been treated in our center between 2000 and 2018 were retrospectively reviewed. Patients were divided into two groups: Group PE (Planned excision; n = 345) and group UE (Unplanned excision; n = 145). Two groups were compared in terms of local recurrence-free survival (LRFS), metastasis-free survival (MFS), and overall survival (OS). Local recur- rences effects over MFS and OS were also analyzed. Results: There were 26 (17.9%) local recurrences in the UE group and 30 (8.7%) local recurrences in the PE group (P = 0.005). There was no difference in MFS and OS between study groups (P= 0.278 and P = 0.848, respectively). Five years MFS rates of UE and PE groups were 76.4% and 73.6%, and five-year OS rates of UE and PE groups were 70.3% and 73.9%, respectively (P= 0.417, P = 0.656). Patients with local recurrence had a 1.96 times higher risk of metastasis than patients without local recurrence (P = 0.008). Patients with local recurrence had 1.65 times higher risk of mortality than patients without local recurrence (P = 0.047). Conclusion: Although local recurrence is much more common in the UE group, this outcome does not seem to affect MFS or OS. These results indicate that similar outcomes can be achieved if UE patients are referred and appropriately treated with wide re-resections.

PDF

___

1. Grimer R, Judson I, Peake D, Seddon B. Guidelines for the management of soft tissue sarcomas. Sarcoma. 2010;2010:506182. [CrossRef]
2. Endo M, Setsu N, Fujiwara T, et al. Diagnosis and management of subcutaneous soft tissue sarcoma. Curr Treat Options Oncol. 2019;20(7):54. [CrossRef]
3. Alramdan MHA, Kasalak Ö, Been LB, Suurmeijer AJH, Yakar D, Kwee TC. MRI after Whoops procedure: diagnostic value for residual sarcoma and predictive value for an incomplete second resection. Skelet Radiol. 2021;50(11):2213-2220. [CrossRef]
4. Pretell-Mazzini J, Barton MD, Conway SA, Temple HT. Unplanned excision of soft-tissue sarcomas: current concepts for management and prognosis. J Bone Joint Surg Am. 2015;97(7):597-603. [CrossRef]
5. Koulaxouzidis G, Schwarzkopf E, Bannasch H, Stark GB. Is revisional surgery mandatory when an unexpected sarcoma diagnosis is made following primary surgery? World J Surg Oncol. 2015;13(1):306. [CrossRef]
6. Decanter G, Stoeckle E, Honore C, et al. Watch and wait approach for re-exci- sion after unplanned yet macroscopically complete excision of extremity and superficial truncal soft tissue sarcoma is safe and does not affect metastatic risk or amputation rate. Ann Surg Oncol. 2019;26(11):3526-3534. [CrossRef]
7. Arai E, Nishida Y, Tsukushi S, Wasa J, Ishiguro N. Clinical and treatment out- comes of planned and unplanned excisions of soft tissue sarcomas. Clin Orthop Relat Res. 2010;468(11):3028-3034. [CrossRef]
8. Smolle MA, Tunn PU, Goldenitsch E, et al. The prognostic impact of unplanned excisions in a cohort of 728 soft tissue sarcoma patients: A multicentre study. Ann Surg Oncol. 2017;24(6):1596-1605. [CrossRef]
9. Scoccianti G, Innocenti M, Frenos F, et al. Re-excision after unplanned excision of soft tissue sarcomas : long-term results. Surg Oncol. 2020;34(April):212-217. [CrossRef]
10. Erol B, Baysal Ö. Does unplanned soft tissue sarcoma surgery have a negative effect on prognosis? J Invest Surg. 2022;35(1):38-43. [CrossRef]
11. Traub F, Griffin AM, Wunder JS, Ferguson PC. Influence of unplanned excisions on the outcomes of patients with stage III extremity soft-tissue sarcoma. Cancer. 2018;124(19):3868-3875. [CrossRef]
12. Benjamin RS, Casper ES. NCCN clinical practice guidelines in oncology (NCCN Guidelines®) soft tissue sarcoma. NCCN.org. version 3.2021. 2012.
13. Potter BK, Adams SC, Pitcher JD, Temple HT. Local recurrence of disease after unplanned excisions of high-grade soft tissue sarcomas. Clin Orthop Relat Res. 2008;466(12):3093-3100. [CrossRef]
14. Rehders A, Stoecklein NH, Poremba C, Alexander A, Knoefel WT, Peiper M. Reexcision of soft tissue sarcoma: sufficient local control but increased rate of metastasis. World J Surg. 2009;33(12):2599-2605. [CrossRef]
15. Qureshi YA, Huddy JR, Miller JD, Strauss DC, Thomas JM, Hayes AJ. Unplanned excision of soft tissue sarcoma results in increased rates of local recurrence despite full further oncological treatment. Ann Surg Oncol. 2012;19(3):871-877. [CrossRef]
16. Nakamura T, Kawai A, Hagi T, Asanuma K, Sudo A. A comparison of clinical outcomes between additional excision after unplanned and planned excisions in patients with soft-tissue sarcoma of the limb: a propensity matching cohort study. Bone Joint J. 2021;103-B(12):1809-1814. [CrossRef]
17. Sacchetti F, Alsina AC, Morganti R, et al. Re-excision after unplanned excision of soft tissue sarcoma: a systematic review and metanalysis. The rationale of systematic re-excision. J Orthop. 2021;25:244-251. [CrossRef]
18. Grimer RJ. Size matters for sarcomas! Ann R Coll Surg Engl. 2006;88(6):519-524. [CrossRef]
19. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14(5):1679-1689. [CrossRef]
20. Singer S, Corson JM, Gonin R, Labow B, Eberlein TJ. Prognostic factors predic- tive of survival and local recurrence for extremity soft tissue sarcoma. Ann Surg. 1994;219(2):165-173. [CrossRef]
21. Dewan V, Darbyshire A, Sumathi V, Jeys L, Grimer R. Prognostic and sur - vival factors in myxofibrosarcomas. Sarcoma. 2012;2012:830879. [CrossRef]
22. Stojadinovic A, Leung DH, Allen P, Lewis JJ, Jaques DP, Brennan MF. Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. J Clin Oncol. 2002;20(21):4344-4352. [CrossRef]
23. Shemesh SS, Garbrecht EL, Rutenberg TF, Conway SA, Rosenberg AE, Pretell- Mazzini J. Unplanned excision of soft tissue sarcoma: does it impact the accu- racy of intra-operative pathologic assessment at time of re-excision? Int Orthop. 2021;45(11):2983-2991. [CrossRef]
24. Chui CH, Spunt SL, Liu T, et al. Is reexcision in pediatric nonrhabdomyosar- coma soft tissue sarcoma necessary after an initial unplanned resection? J Pedi- atr Surg. 2002;37(10):1424-1429. [CrossRef]
25. Hanasilo CE, Casadei MS, Auletta L, Amstalden EM, Matte SR, Etchebehere M. Comparative study of planned and unplanned excisions for the treatment of soft tissue sarcoma of the extremities. Clinics (Sao Paulo). 2014;69(9):579-584. [CrossRef]
26. Gingrich AA, Elias A, Michael Lee CY, et al. Predictors of residual disease after unplanned excision of soft tissue sarcomas. J Surg Res. 2017;208:26-32. [CrossRef]
27. Kaste SC, Hill A, Conley L, Shidler TJ, Rao BN, Neel MM. Magnetic resonance imaging after incomplete resection of soft tissue sarcoma. Clin Orthop Relat Res. 2002;397(397):204-211. [CrossRef]